News for AC Immune Stock (ACIU)

Are Medical Stocks Lagging AC Immune (ACIU) This Year?

Zacks Investment Research • 11/09/23

AC Immune to Present at the Jefferies 2023 London Healthcare Conference

GlobeNewsWire • 11/07/23

AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update

GlobeNewsWire • 11/03/23

AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer's Disease as a Surrogate of Clinical Efficacy on November 9, 2023

GlobeNewsWire • 11/02/23

AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic

GlobeNewsWire • 10/27/23

Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year?

Zacks Investment Research • 10/24/23

AC Immune (ACIU) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Zacks Investment Research • 10/20/23

AC Immune Announces Upcoming Presentations at the 16th CTAD Conference

GlobeNewsWire • 10/17/23

AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023

GlobeNewsWire • 10/05/23

AC Immune (ACIU) Surges 43% in the Past 3 Months: Here's Why

Zacks Investment Research • 09/05/23

AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023

GlobeNewsWire • 09/05/23

AC Immune (ACIU) Reports Q2 Loss, Misses Revenue Estimates

Zacks Investment Research • 08/04/23

AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update

GlobeNewsWire • 08/04/23

AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023

GlobeNewsWire • 07/28/23

AC Immune SA Appoints New Chief Medical Officer

GlobeNewsWire • 07/26/23

AC Immune Showcasing Precision Medicine Programs at AAIC 2023

GlobeNewsWire • 07/03/23

Why Shares of AC Immune Jumped This Week

The Motley Fool • 06/30/23

Trading Penny Stocks With Limited Capital: 3 Tops Tips

PennyStocks • 06/28/23

AC Immune's stock soars 13% after FDA grants fast-track designation to Alzheimer's treatment

Market Watch • 06/27/23

AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer's Disease

GlobeNewsWire • 06/27/23

AC Immune Holds Annual General Meeting of Shareholders

GlobeNewsWire • 06/23/23

AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update

GlobeNewsWire • 04/28/23

7 Biotech Stocks With Huge Return Potential for Long-Term Investors

InvestorPlace • 04/27/23

AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer's Disease

GlobeNewsWire • 04/05/23

AC Immune at AD/PD™ 2023 to Present New Clinical and Preclinical Data from its Precision Medicine Pipeline

GlobeNewsWire • 03/20/23